Antiviral methods employing double esters of 2′,...

Details Antiviral methods employing double esters of 2′,... Antiviral methods employing double esters of 2′,...

2006-07-04

2006-07-04

Wilson, James O. (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S048000, C536S022100, C536S027100, C536S027130, C536S027140, C536S027200

Reexamination Certificate

active

07071173

ABSTRACT:
A method for treatment of HBV and HIV infections comprising administering the compound or salt of formula Ig

REFERENCES:
patent: 3705191 (1972-12-01), Kerst
patent: 4168267 (1979-09-01), Petrillo, Jr.
patent: 4309364 (1982-01-01), Bentzen et al.
patent: 4337201 (1982-06-01), Petrillo, Jr.
patent: 4486425 (1984-12-01), Nakao
patent: 4594199 (1986-06-01), Thottathil
patent: 4760057 (1988-07-01), Alexander
patent: 4942157 (1990-07-01), Gall et al.
patent: 4957924 (1990-09-01), Beauchamp
patent: 4963662 (1990-10-01), Matthes et al.
patent: 5001115 (1991-03-01), Sloan
patent: 5073641 (1991-12-01), Bundgaard et al.
patent: 5198539 (1993-03-01), Rahim et al.
patent: 5227506 (1993-07-01), Saari et al.
patent: 5376649 (1994-12-01), Pohjala et al.
patent: 5441942 (1995-08-01), Goodman et al.
patent: 5466811 (1995-11-01), Alexander
patent: 5484911 (1996-01-01), Hong et al.
patent: 5543414 (1996-08-01), Nestor et al.
patent: 5618804 (1997-04-01), Kawabe et al.
patent: 5624897 (1997-04-01), Jeschke et al.
patent: 5624917 (1997-04-01), Kitano et al.
patent: 5717095 (1998-02-01), Arimilli et al.
patent: 6458772 (2002-10-01), Zhou et al.
patent: 2002/0142969 (2002-10-01), Jeschke et al.
patent: 2003/0139369 (2003-07-01), Yeadon
patent: 2112057 (1971-09-01), None
patent: 195 29 604 (1995-08-01), None
patent: 176 217 (1986-04-01), None
patent: 372 268 (1990-06-01), None
patent: 0375329 (1990-06-01), None
patent: 658 551 (1995-06-01), None
patent: 0694547 (1996-01-01), None
patent: 05-229997 (1993-09-01), None
patent: WO8800050 (1988-01-01), None
patent: WO8903837 (1989-05-01), None
patent: WO9008128 (1990-07-01), None
patent: WO9008155 (1990-07-01), None
patent: WO 91/06554 (1991-05-01), None
patent: WO9119721 (1991-12-01), None
patent: WO9200988 (1992-01-01), None
patent: WO9213561 (1992-08-01), None
patent: WO9413324 (1994-06-01), None
patent: WO9424134 (1994-10-01), None
patent: WO9501363 (1995-01-01), None
patent: WO9512604 (1995-05-01), None
patent: WO9512605 (1995-05-01), None
patent: WO9514016 (1995-05-01), None
patent: WO9532984 (1995-12-01), None
patent: WO9615132 (1996-05-01), None
patent: WO9621440 (1996-07-01), None
patent: WO9622303 (1996-07-01), None
patent: WO9631227 (1996-10-01), None
patent: WO9633201 (1996-10-01), None
patent: WO9705154 (1997-02-01), None
patent: WO9727194 (1997-07-01), None
patent: WO9730051 (1997-08-01), None
patent: WO9821223 (1998-05-01), None
patent: WO9846576 (1998-10-01), None
patent: WO9851692 (1998-11-01), None
Tetrehedron Letters, 30 (51) 1989, 7141-44, Iyer, R et al “Synthesis of Acyloxyalkyl Acylphosphonates . . . ”
J Med Chem 39 (1) 1996, 10-18, Robinson, R et al “Discovery of the Hemifumarate and . . . ”
International J of Pharmaceutics 104 (1994) 157-67, Walker, I et al. “Drug delivery via active transport at the blood-brain barrier: affinity . . . ”
Abstract of WO 98/11126, Sep. 9, 1997, Larsen, B et al. “Peptide prodrugs containing an alpha-hydroxyacid linker”.
Meziane-Cherif, D. et al., “Purification and characterization of the VanB . . . ,” FEBS Letters 354 (1994) pp. 141-142.
Ohyama, M. et al., “Total Synthesis of the Anthelmintic . . . ,” Biosci. Biotech. Biochem. (1994), 58 (6), pp. 1193-1194.
Wu, Z. et al., “Overexperssion, Purification, and Characterization . . . ,” Biochemistry (1995), 34, pp. 2455-2463.
Nyeki, O. et al., “Synthesis of Angiotensin II . . . ,” J. Med. Chem. (1987), 30, pp. 1719-1724.
Kigasawa, K. et al., “Decomposition and Stabilization of Drugs . . . ,” Yakugaku Zasshi (1979), 99, pp. 402-412.
Schacht, E. et al., “Biomedical Applications of Degradable . . . ,” Biotechnology and Bioengineering (1996), 52, pp. 102-108.

Affiliated with

Also associated with

Rating

Antiviral methods employing double esters of 2′,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral methods employing double esters of 2′,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral methods employing double esters of 2′,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3561412